Below are the most recent publications written about "Shock, Septic" by people in Profiles.
-
Neyra JA, Legrand M, Tidswell MA, Al-Khafaji A, Galphin C, Rains R, Davison D, Tolwani A, Chen JT, Bender WS, Busse LW, Meena NK, DellaVolpe J, Williams GW, Kashani KB, Gunnerson KJ, McMahon BA, Eaton J, Khan S, Kohli-Seth R, Jagpal S, Klein D, Kamaluddin E, Foster DM, Walker PM, Tomlinson G, Kellum JA. Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trial. Lancet Respir Med. 2026 May; 14(5):443-452.
-
Molinari L, Tidswell MA, Al-Khafaji A, Davison D, Galphin C, Kamaluddin E, Foster DM, Kellum JA. Organ Failure, Endotoxin Activity, and Mortality in Septic Shock. Crit Care Explor. 2025 Sep 01; 7(9):e1308.
-
Teja B, Berube M, Pereira TV, Law AC, Schanock C, Pang B, Wunsch H, Walkey AJ, Bosch NA. Effectiveness of Fludrocortisone Plus Hydrocortisone versus Hydrocortisone Alone in Septic Shock: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Am J Respir Crit Care Med. 2024 05 15; 209(10):1219-1228.
-
Bracey A, Sherman MH. Midline Catheters Are the Optimal Vascular Access Device For Managing Septic Shock in the Emergency Department. Ann Emerg Med. 2024 06; 83(6):605-606.
-
Tomlinson G, Al-Khafaji A, Conrad SA, Factora FNF, Foster DM, Galphin C, Gunnerson KJ, Khan S, Kohli-Seth R, McCarthy P, Meena NK, Pearl RG, Rachoin JS, Rains R, Seneff M, Tidswell M, Walker PM, Kellum JA. Bayesian methods: a potential path forward for sepsis trials. Crit Care. 2023 11 08; 27(1):432.
-
Bosch NA, Teja B, Law AC, Wunsch H, Walkey AJ. Arterial Pressure Response to an Increase in Norepinephrine Varies Depending on the Baseline Norepinephrine Dose in Patients With Septic Shock. Chest. 2023 11; 164(5):1228-1231.
-
Bosch NA, Teja B, Law AC, Pang B, Jafarzadeh SR, Walkey AJ. Comparative Effectiveness of Fludrocortisone and Hydrocortisone vs Hydrocortisone Alone Among Patients With Septic Shock. JAMA Intern Med. 2023 05 01; 183(5):451-459.
-
Boccio E, Haimovich A, Jacob V, Zhao X, Wira CR, Venkatesh A, Belsky J. Establishment of SEP-1 national practice guidelines does not impact fluid administration for septic shock patients. Am J Emerg Med. 2022 12; 62:19-24.
-
Teja B, Bosch NA, Wijeysundera DN, Wijeysundera HC, Saskin R, Hill AD, Stelfox HT, Walkey AJ, Wunsch H. First-Line Vasopressor Use in Septic Shock and Route of Administration: An Epidemiologic Study. Ann Am Thorac Soc. 2022 10; 19(10):1713-1721.
-
Teja B, Bosch NA, Walkey AJ. How We Escalate Vasopressor and Corticosteroid Therapy in Patients With Septic Shock. Chest. 2023 03; 163(3):567-574.